Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-385-8 | CAS number: 120-32-1
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 Jun - 12 Jul 1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted in 1981
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted in 1987
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- other: acute oral toxicity
- Limit test:
- no
Test material
- Reference substance name:
- Clorofene
- EC Number:
- 204-385-8
- EC Name:
- Clorofene
- Cas Number:
- 120-32-1
- Molecular formula:
- C13H11ClO
- IUPAC Name:
- clorofene
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (U.K.) Limited
- Age at study initiation: about 40 days
- Weight at study initiation: 118 - 206 g (males), 120 - 164 g (females)
- Housing: 5 animals of the same sex per cage in high density polypropylene cages (56 x 38 x 18 cm) with stainless steel grid floors and top
- Diet: Laboratory Diet No. 1, pelleted (K and K Greeff Chemicals Ltd.), ad libitum (except for the removal of food approximately 18 h before rats were given the test material by gavage)
- Water: tap water, ad libitum
- Acclimation period: at least seven days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 (18 - 25 acceptable limits)
- Humidity (%): 55 (40 - 65 acceptable limits)
- Air changes (per hr): approximately 17
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- maize oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 1500, 2500, 3150, 3969 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed at least at three separate inspections during the first hour after administration and twice daily after Day 2. Inspection for decedents was conducted three times daily and two times at weekends. Individual bodyweights were determined on the day before dosing and on Days 1, 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- Acute median lethal dose, 95% confidence interval and slope of the dose response curve for both sexes was determined by probit analysis. When probit analysis failed to demonstrate a linear dosage/mortality response curve, the LD50 and 95% confidence interval were calculated using the method of moving average interpolation after Thompson.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 462 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 4 383 - <= 4 545
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 3 852 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 3 128 - <= 4 838
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 147 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 3 783 - <= 4 608
- Mortality:
- 1500 and 2000 mg/kg bw: no mortalities occured
3150 mg/kg bw: 1/5 female died (at 1 - 3 day post dose)
3969 mg/kg bw: 1/5 male died (at 1 - 5 day post dose) and 2/5 females died (at 1 - 3 day and 1 - 4 day post dose)
5000 mg/kg bw: 4/5 males died (at 2 - 2 day and 2 - 3 day post dose) and 5/5 females died (at 1 - 2 day, 2 - 3 day, 1 - 4 day post dose) - Clinical signs:
- 1500 mg/kg bw: ungroomed appearance (Day 2)
2500 mg/kg bw: ungroomed appearance (Day 2)
3150 mg/kg bw: diarrhoe, hunched posture and decreased motor activity (between 30 min and 1 h post dose); ungroomed appearance (Day 2)
3969 mg/kg bw: diarrhoe, hunched posture and decreased motor activity (between 30 min and 1 h post dose); ungroomed appearance (Day 2)
5000 mg/kg bw: diarrhoe, hunched posture and decreased motor activity (between 30 min and 1 h post dose); transient periods of irritability and hyperpnoea (during 30 min post dose in occasional decedents); ungroomed appearance and pigmented staining of the snout (Day 2)
All surviving animals at 2500 mg/kg bw or more continued to show ungroomed appearance for varying length of time up to Day 7. Several animals amongst the higher treatment groups also displayed pigmented staining of the snout until Day 4. Other infrequently observed signs during this period included pigmented orbital secretion and thin body conformation. No abnormality was observed after Day 7. - Body weight:
- No effect on body weight was noted.
- Gross pathology:
- Necropsy of decedents revealed abnormal gastrointestinal contents in the majority of animals. Superficial staining of the mouth, nares, forelimbs, head, urogenital area or general body surfaces was also observed in many animals. Other less frequently noticed gross pathological findings included congestion or haemorrhage of the thymus, slight congestion or incomplete collapse of the lungs and congestion of the brain.
Necropsy of survivors revealed fibrous adhesions between the stomach and adjacent tissues of the left lobe of the liver and abdominal wall in 4 males and one female treated with 3969 mg/kg bw. A low incidence of gastrointestinal contents, slight or moderate hydronephrosis and slight congestion of the lungs was observed in rats of the lower dose groups.
Any other information on results incl. tables
Table 1: Results of acute oral toxicity testing
Males |
||||
Dose [mg/kg bw] |
Toxicological results* |
Duration of signs |
Time of death |
Mortality (%) |
1500 |
0/5/5 |
Day 2 |
- |
0 |
2500 |
0/5/5 |
4 h - Day 3 |
- |
0 |
3150 |
0/5/5 |
1 h - Day 7 |
- |
0 |
3969 |
1/5/5 |
1 h - Day 8 |
Day 5 |
20 |
5000 |
4/5/5 |
15 min - Day 5 |
Day 2 |
80 |
LD50= 4462 mg/kg bw |
||||
Females |
||||
1500 |
0/5/5 |
Day 2 |
- |
0 |
2500 |
0/5/5 |
4 h - Day 3 |
- |
0 |
3150 |
1/5/5 |
1 h - Day 8 |
Day 4 |
20 |
3969 |
2/5/5 |
1 h - Day 8 |
Day 3 |
40 |
5000 |
5/5/5 |
15 min - death |
Day 1-2 |
100 |
LD50= 3852 mg/kg bw |
||||
* number of dead animals/number of animals with signs of toxicity/total number of animals tested
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/GHS criteria not met; no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- CLP: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
